Article
Big Pharma's Balancing Act: Navigating Patent Thickets In The Age Of Biosimilars
The rise of biosimilars is transforming the pharmaceutical landscape, and Big Pharma is keenly aware that the fate of their blockbuster biologic drugs' exclusivity is at stake.
WIT Legal
